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Editors’ NotesSafety in Cell Lines
The question of safety with respect to using pluripotent stem cells in therapeutic applications is a major and ongoing concern,
perhaps even more so in light of recent reports regarding the instability and immunogenicity of iPSCs. The Goldring et al.
Perspective article shares the views of a panel of academic and commercial experts on this topic, and offers a road map for
thedevelopmentof appropriate safetyassessment criteria.AsSridharanandPlathdiscuss in theirPreview,Mori andcolleagues
have succeeded in reprogramming adult human cells following the repeated transfection of a collection of mature miRNAs.
Their approach, while not as efficient as the recent miR-iPSCmethod from the Morrisey group (8:376), may offer an improved
safety profile, given that viral gene transfer is not required. Moving forward from iPSC generation, Belmonte and colleagues
describe an efficient method for correcting genetic mutations in hiPSCs through homologous recombination, illustrated by
rescue of multiple laminopathy-associated LMNA mutations. They also show that this approach can correct mutations in
MSCs. Thismethodmight therefore allow the reversal of genetic imperfec-
tions in patient-specific lines and/or stemcell populations, therebyoffering
anotherpotential route forsafe therapeuticapplication,aswell asamethod
for disease modeling and drug discovery in preclinical settings.
Differentiating Expression
Reprogramming is also relevant for generating specific differentiated
progeny, as Perlmann and coauthors highlight by converting the progeny
of human and mouse ESCs into specific neuron subsets with the expres-
sion of particular combinations of neural transcription factors. The result-
ing production of relatively homogeneous populations of dopaminergic,
serotonergic, or specificmotor neuronsenables informative global geneexpressionanalyses thatprovide insight into cell types
that previously proved inaccessible for population-based study. Studer and colleagues also look at expression data, this time
inahost of pluripotent cell lines for thepurposeof identifying line-specificpropensities for neural differentiation. They found that
the expression of miR-371-3 predicted the capacity for both hESC and hiPSC lines to generate progeny with in vivo dopamine
neuron engraftment potential, and that KLF4 plays a regulatory role in this cascade. Karimi et al. look at pluripotent gene
silencing, rather than expression, and find that in the absence of the H3K9methyltransferase SETDB1, many genes, including
endogenous retroviral transcripts, become derepressed. Interestingly, this method of inhibiting aberrant gene transcription
appears distinct from the regulation by DNMT DNA methyltransferases, and SETDB1-deficient mESCs express so-called
‘‘chimeric’’ transcripts that combine retroelement sequences with genic exons.
Damaging Fate
In their Research article, So and colleagues also examine the impact of epigenetic regulators by using transcription factor
fusion proteins to induce leukemia in the absence of the polycomb family repressor and stem cell renewal factor Bmi-1,
with or without Hox family activation. They find that either Bmi-1 or Hoxa9 are required to
permit transformation by the MLL-AF9 fusion oncogene, and that each polycomb member
can replace the other in double knockout animals. Thus, the fate of putative leukemia stem
cells (LSCs) may depend on signals from both of these modifiers, and the authors predict
that targeting both molecules might enhance the capacity to eradicate tumor-forming popu-
lations on a broader scale. Hogan and coauthors were also interested in how stem cell fates
canbemodified, but used the epithelial lining of small airways as theirmodel. Basal cells in the
mouse lung are an established source of multilineage progeny in this tissue, but the signaling
pathways responsible for their response to injury have been relatively unclear. Using reporter
alleles and both gain- and loss-of-function assays during the repair of airway damage, the
authors demonstrate that the Notch pathway is required for the differentiation, but not the
maintenance, of the basal cell population in the adult. Sustained Notch signaling promoted
secretory lineage production, and this pattern was also observed in human airway basal cells.
Lines of Communication
As youmight guess from this month’s cover image, we are celebratingCell Stem Cell’s fourth
anniversarywith a collectionof articles that focuson formsof communication that areongoing,
or needed, among our diverse community as we move basic stem cell research closer to the clinic. One example is the Forum
article from Haimes and Taylor, who comment on the value of promoting communication between human reproductive tissue
providers, the scientists who use them, and the intermediate parties who procure the material for research purposes. They
propose several sets of questions that, if studied, could clarify the nature of the relationships between these groups, and result
in an efficient, ethical supply of human tissue for experimental inquiry. Elaine Fuchs also promotes communication within the
diverse stem cell community in her outgoing ISSCR Presidential address, and Letters from Yamanaka and colleagues as
well as the ATCC continue an ongoing conversation opened by Luong and coauthors in their earlier Forumarticle (8:357) calling
for consensus in nomenclature standards for human pluripotent cells. Be sure to check out Deborah Sweet’s Editorial for more
news about our anniversary issue, and the many initiatives that CSC has on tap for the year to come.Cell Stem Cell 8, June 3, 2011 ª2011 Elsevier Inc. xv
